The inflammatory airway disease cystic fibrosis (CF) is characterized by airway obstruction due to mucus hypersecretion, airway plugging, and bronchoconstriction. The cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel is dysfunctional in CF, leading to defects in epithelial transport. Although CF pathogenesis is still disputed, activation of alternative Cl- channels is assumed to improve lung function in CF. Two suitable non-CFTR Cl- channels are present in the airway epithelium, the Ca2+ activated channel TMEM16A and SLC26A9. Activation of these channels is thought to be feasible to improve hydration of the airway mucus and to increase mucociliary clearance. Interestingly, both channels are upregulated during inflammatory lung disease. They are assumed to support fluid secretion, necessary to hydrate excess mucus and to maintain mucus clearance. During inflammation, however, TMEM16A is upregulated particularly in mucus producing cells, with only little expression in ciliated cells. Recently it was shown that knockout of TMEM16A in ciliated cells strongly compromises Cl- conductance and attenuated mucus secretion, but does not lead to a CF-like lung disease and airway plugging. Along this line, activation of TMEM16A by denufosol, a stable purinergic ligand, failed to demonstrate any benefit to CF patients in earlier studies. It rather induced adverse effects such as cough. A number of studies suggest that TMEM16A is essential for mucus secretion and possibly also for mucus production. Evidence is now provided for a crucial role of TMEM16A in fusion of mucus-filled granules with the apical plasma membrane and cellular exocytosis. This is probably due to local Ca2+ signals facilitated by TMEM16A. Taken together, TMEM16A supports fluid secretion by ciliated airway epithelial cells, but also maintains excessive mucus secretion during inflammatory airway disease. Because TMEM16A also supports airway smooth muscle contraction, inhibition rather than activation of TMEM16A might be the appropriate treatment for CF lung disease, asthma and COPD. As a number of FDA-approved and well-tolerated drugs have been shown to inhibit TMEM16A, evaluation in clinical trials appears timely.

Department of Pediatrics 2nd Faculty of Medicine University Hospital Motol Charles University Prague Prague Czechia

Innere Medizin 1 Klinikum Rechts der Isar der TU München München Germany

Institut für Physiologie Universität Regensburg Regensburg Germany

Institute of Molecular Animal Breeding and Biotechnology Ludwig Maximilians Universität München Munich Germany

Zobrazit více v PubMed

Accurso F. J., Rowe S. M., Clancy J. P., Boyle M. P., Dunitz J. M., Durie P. R., et al. . (2010). Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N. Engl. J. Med. 363, 1991–2003. 10.1056/NEJMoa0909825 PubMed DOI PMC

Amaral M. D., Kunzelmann K. (2007). Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis. Trends Pharmacol. Sci. 28, 334–341. 10.1016/j.tips.2007.05.004 PubMed DOI

Anagnostopoulou P., Riederer B., Duerr J., Michel S., Binia A., Agrawal R., et al. . (2012). SLC26A9-mediated chloride secretion prevents mucus obstruction in airway inflammation. J. Clin. Invest. 122, 3629–3634. 10.1172/JCI60429 PubMed DOI PMC

Angles F., Hutt D., Balch W. E. (2018). HDAC inhibitors rescue multiple disease-causing CFTR variants. bioRxiv. 10.1101/399451 PubMed DOI PMC

Baron A., Pacaud P., Loirand G., Mironneau C., Mironneau J. (1991). Pharmacological block of Ca2+-activated Cl− current in rat vascular smooth muscle cells in short-term primary culture. Pflugers Arch. 419, 553–558. 10.1007/BF00370294 PubMed DOI

Benedetto R., Cabrita I., Schreiber R., Kunzelmann K. (2019). TMEM16A is indispensable for basal mucus secretion in airways and intestine. FASEB J. [Epub ahead of print]. 10.1096/fj.201801333RRR PubMed DOI

Benedetto R., Ousingsawat J., Wanitchakool P., Zhang Y., Holtzman M. J., Amaral M., et al. . (2017). Epithelial chloride transport by CFTR requires TMEM16A. Sci. Rep. 7:12397. 10.1038/s41598-017-10910-0 PubMed DOI PMC

Benedetto R., Sirianant L., Pankonien I., Wanitchakool P., Ousingsawat J., Cabrita I., et al. . (2016). Relationship between TMEM16A/anoctamin 1 and LRRC8A. Pflugers Arch. 468, 1751–1763. 10.1007/s00424-016-1862-1 PubMed DOI

Bertrand C. A., Mitra S., Mishra S. K., Wang X., Zhao Y., Pilewski J. M., et al. . (2017). The CFTR trafficking mutation F508del inhibits the constitutive activity of SLC26A9. Am. J. Physiol. Lung Cell. Mol. Physiol. 312, L912–L925. 10.1152/ajplung.00178.2016 PubMed DOI PMC

Bertrand C. A., Zhang R., Pilewski J. M., Frizzell R. A. (2009). SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia. J. Gen. Physiol. 133, 421–438. 10.1085/jgp.200810097 PubMed DOI PMC

Billet A., Hanrahan J. W. (2013). The secret life of CFTR as a calcium-activated chloride channel. J. Physiol. 591, 5273–5278. 10.1113/jphysiol.2013.261909 PubMed DOI PMC

Boucher R. C. (2007). Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu. Rev. Med. 58, 157–170. 10.1146/annurev.med.58.071905.105316 PubMed DOI

Boucher R. C., Stutts M. J., Knowles M. R., Cantley L., Gatzy J. T. (1986). Na+ transport in cystic fibrosis respiratory epithelia: abnormal basal rate and response to adenylate cyclase. J. Clin. Invest. 78, 1245–1252. 10.1172/JCI112708 PubMed DOI PMC

Brightling C. E., Bradding P., Symon F. A., Holgate S. T., Wardlaw A. J., Pavord I. D. (2002). Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 346, 1699–1705. 10.1056/NEJMoa012705 PubMed DOI

Burris S. K., Wang Q., Bulley S., Neeb Z. P., Jaggar J. H. (2015). 9-phenanthrol inhibits recombinant and arterial myocyte TMEM16A channels. Br. J. Pharmacol. 172, 2459–2468. 10.1111/bph.13077 PubMed DOI PMC

Button B., Goodell H. P., Atieh E., Chen Y. C., Williams R., Shenoy S., et al. . (2018). Roles of mucus adhesion and cohesion in cough clearance. Proc. Natl. Acad. Sci. U.S.A. 115, 12501–12506. 10.1073/pnas.1811787115 PubMed DOI PMC

Cabrita I., Benedetto R., Fonseca A., Wanitchakool P., Sirianant L., Skryabin B. V., et al. . (2017). Differential effects of anoctamins on intracellular calcium signals. FASEB J. 31, 2123–2134. 10.1096/fj.201600797RR PubMed DOI

Caci E., Scudieri P., Di Carlo E., Morelli P., Bruno S., De F., et al. . (2015). Upregulation of TMEM16A protein in bronchial epithelial cells by bacterial pyocyanin. PLoS ONE 10:e0131775. 10.1371/journal.pone.0131775 PubMed DOI PMC

Caputo A., Caci E., Ferrera L., Pedemonte N., Barsanti C., Sondo E., et al. . (2008). TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science 322, 590–594. 10.1126/science.1163518 PubMed DOI

Carlile G. W., Robert R., Goepp J., Matthes E., Liao J., Kus B., et al. . (2015). Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking. J. Cyst. Fibros. 14, 16–25. 10.1016/j.jcf.2014.06.001 PubMed DOI

Carlile G. W., Yang Q., Matthes E., Liao J., Radinovic S., Miyamoto C., et al. . (2018). A novel triple combination of pharmacological chaperones improves F508del-CFTR correction. Sci. Rep. 8:11404. 10.1038/s41598-018-29276-y PubMed DOI PMC

Catalan M. A., Kondo Y., Pena-Munzenmayer G., Jaramillo Y., Liu F., Choi S., et al. . (2015). A fluid secretion pathway unmasked by acinar-specific Tmem16A gene ablation in the adult mouse salivary gland. Proc. Natl. Acad. Sci U.S.A. 112, 2263–2268. 10.1073/pnas.1415739112 PubMed DOI PMC

Chai R., Chen Y., Yuan H., Wang X., Guo S., Qi J., et al. . (2017). Identification of resveratrol, an herbal compound, as an activator of the calcium-activated chloride channel, TMEM16A. J. Membr. Biol. 250, 483–492. 10.1007/s00232-017-9975-9 PubMed DOI

Chang M. H., Plata C., Sindic A., Ranatunga W. K., Chen A. P., Zandi-Nejad K., et al. (2009). Slc26a9 is inhibited by the R-region of CFTR via the STAS domain. J. Biol. Chem. 284, 28306–28318. 10.1074/jbc.M109.001669 PubMed DOI PMC

Chen J. H., Stoltz D. A., Karp P. H., Ernst S. E., Pezzulo A. A., Moninger T. O., et al. . (2010). Loss of anion transport without increased sodium absorption characterizes newborn porcine cystic fibrosis airway epithelia. Cell 143, 911–923. 10.1016/j.cell.2010.11.029 PubMed DOI PMC

Chin S., Hung M., Won A., Wu Y. S., Ahmadi S., Yang D., et al. . (2018). Lipophilicity of the cystic fibrosis drug, ivacaftor (VX-770), and its destabilizing effect on the major CF-causing mutation: F508del. Mol. Pharmacol. 94, 917–925. 10.1124/mol.118.112177 PubMed DOI

Cho H., Yang Y. D., Lee J., Lee B., Kim T., Jang Y., et al. . (2012). The calcium-activated chloride channel anoctamin 1 acts as a heat sensor in nociceptive neurons. Nat. Neurosci. 15, 1015–1021. 10.1038/nn.3111 PubMed DOI

Choi J. Y., Muallem D., Kiselyov K., Lee M. G., Thomas P. J., Muallem S. (2001). Aberrant CFTR-dependent HCO3- transport in mutations associated with cystic fibrosis. Nature 410, 94–97. 10.1038/35065099 PubMed DOI PMC

Cholon D. M., Quinney N. L., Fulcher M. L., Esther C. R., Jr., Das J., Dokholyan N. V., et al. . (2014). Potentiator ivacaftor abrogates pharmacological correction of DeltaF508 CFTR in cystic fibrosis. Sci. Transl. Med. 6:246ra296. 10.1126/scitranslmed.3008680 PubMed DOI PMC

Cotton C. U., Lawson E. E., Boucher R. C., Gatzy J. T. (1983). Bioelectric properties and ion transport of airways excised from adult and fetal sheep. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 55, 1542–1549. 10.1152/jappl.1983.55.5.1542 PubMed DOI

Danielsson J., Mikami M., Emala C. W. (2017). Antagonism of the Tmem16a calcium-activated chloride channel attenuates allergic lung inflammation. Am. J. Respir. Crit. Care Med. 195:A5290.

Danielsson J., Perez-Zoghbi J., Bernstein K., Barajas M. B., Zhang Y., Kumar S., et al. . (2015). Antagonists of the TMEM16A calcium-activated chloride channel modulate airway smooth muscle tone and intracellular calcium. Anesthesiology 123, 569–581. 10.1097/ALN.0000000000000769 PubMed DOI PMC

Davies J. C., Moskowitz S. M., Brown C., Horsley A., Mall M. A., Mckone E. F., et al. (2018). VX-659-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles. N. Engl. J. Med. 379, 1599–1611. 10.1056/NEJMoa1807119 PubMed DOI PMC

De Boeck K., Amaral M. D. (2016). Progress in therapies for cystic fibrosis. Lancet Respir. Med. 4, 662–674. 10.1016/S2213-2600(16)00023-0 PubMed DOI

De Boeck K., Zolin A., Cuppens H., Olesen H. V., Viviani L. (2014). The relative frequency of CFTR mutation classes in European patients with cystic fibrosis. J. Cyst. Fibros. 13, 403–409. 10.1016/j.jcf.2013.12.003 PubMed DOI

de La Fuente R., Namkung W., Mills A., Verkman A. S. (2007). Small molecule screen identifies inhibitors of a human intestinal calcium activated chloride channel. Mol. Pharmacol. 73, 758–768. 10.1124/mol.107.043208 PubMed DOI

Deba F., Bessac B. F. (2015). Anoctamin-1 Cl channels in nociception: activation by an N-aroylaminothiazole and capsaicin and inhibition by T16A[inh]-A01. Mol. Pain 11:55. 10.1186/s12990-015-0061-y PubMed DOI PMC

Donaldson S. H., Boucher R. C. (2007). Sodium channels and cystic fibrosis. Chest 132, 1631–1636. 10.1378/chest.07-0288 PubMed DOI

Donaldson S. H., Pilewski J. M., Griese M., Cooke J., Viswanathan L., Tullis E., et al. . (2018). Tezacaftor/Ivacaftor in subjects with cystic fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR. Am. J. Respir. Crit. Care Med. 197, 214–224. 10.1164/rccm.201704-0717OC PubMed DOI PMC

Doring G., Worlitzsch D. (2000). Inflammation in cystic fibrosis and its management. Paediatr. Respir. Rev. 1, 101–106. 10.1053/prrv.2000.0030 PubMed DOI

Dorwart M. R., Shcheynikov N., Wang Y., Stippec S., Muallem S. (2007). SLC26A9 is a Cl(-) channel regulated by the WNK kinases. J. Physiol. 584, 333–345. 10.1113/jphysiol.2007.135855 PubMed DOI PMC

Drumm B. T., Hennig G. W., Battersby M. J., Cunningham E. K., Sung T. S., Ward S. M., et al. (2017). Clustering of Ca2+) transients in interstitial cells of cajal defines slow wave duration. J. Gen. Physiol. 149, 703–725. 10.1085/jgp.201711771 PubMed DOI PMC

Dunican E. M., Elicker B. M., Gierada D. S., Nagle S. K., Schiebler M. L., Newell J. D., et al. . (2018). Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction. J. Clin. Invest. 128, 997–1009. 10.1172/JCI95693 PubMed DOI PMC

El Khouri E., Toure A. (2014). Functional interaction of the cystic fibrosis transmembrane conductance regulator with members of the SLC26 family of anion transporters (SLC26A8 and SLC26A9): physiological and pathophysiological relevance. Int. J. Biochem. Cell Biol. 52, 58–67. 10.1016/j.biocel.2014.02.001 PubMed DOI

Fahy J. V., Dickey B. F. (2010). Airway mucus function and dysfunction. N. Engl. J. Med. 363, 2233–2247. 10.1056/NEJMra0910061 PubMed DOI PMC

Faria D., Schlatter E., Witzgall R., Grahammer F., Bandulik S., Schweda F., et al. . (2014). The calcium activated chloride channel Anoctamin 1 contributes to the regulation of renal function. Kindey Int. 85, 1369–1381. 10.1038/ki.2013.535 PubMed DOI

Faria D., Schreiber R., Kunzelmann K. (2009). CFTR is activated through stimulation of purinergic P2Y2 receptors. Pflügers Arch. 457, 1373–1380. 10.1007/s00424-008-0606-2 PubMed DOI

Fedigan S., Bradley E., Webb T., Large R. J., Hollywood M. A., Thornbury K. D., et al. . (2017). Effects of new-generation TMEM16A inhibitors on calcium-activated chloride currents in rabbit urethral interstitial cells of cajal. Pflugers Arch. 469, 1443–1455. 10.1007/s00424-017-2028-5 PubMed DOI

Ferkol T., Quinton P. (2015). Precision medicine: at what price? Am. J. Respir. Crit. Care Med. 192, 658–659. 10.1164/rccm.201507-1428ED PubMed DOI

Galietta L. J., Pagesy P., Folli C., Caci E., Romio L., Costes B., et al. . (2002). IL-4 is a potent modulator of ion transport in the human bronchial epithelium in vitro. J. Immunol. 168, 839–845. 10.4049/jimmunol.168.2.839 PubMed DOI

Galli S. J., Tsai M., Piliponsky A. M. (2008). The development of allergic inflammation. Nature 454, 445–454. 10.1038/nature07204 PubMed DOI PMC

Gallos G., Remy K. E., Danielsson J., Funayama H., Fu X. W., Chang H. Y., et al. . (2013). Functional expression of the TMEM16 family of calcium activated chloride channels in airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 305, L625–L634. 10.1152/ajplung.00068.2013 PubMed DOI PMC

Gianotti A., Ferrera L., Philp A. R., Caci E., Zegarra-Moran O., Galietta L. J., et al. (2016). Pharmacological analysis of epithelial chloride secretion mechanisms in adult murine airways. Eur. J. Pharmacol. 787, 100–108. 10.1016/j.ejphar.2016.04.007 PubMed DOI

Grubb B. R., Vick R. N., Boucher R. C. (1994). Hyperabsorption of Na+ and raised Ca2+ mediated Cl− secretion in nasal epithelia of CF mice. Am. J. Physiol. 266, C1478–C1483. 10.1152/ajpcell.1994.266.5.C1478 PubMed DOI

Grubb S., Poulsen K. A., Juul C. A., Kyed T., Klausen T. K., Larsen E. H., et al. (2013). TMEM16F (Anoctamin 6), an anion channel of delayed Ca2+ activation. J. Gen. Physiol. 141, 585–600. 10.1085/jgp.201210861 PubMed DOI PMC

Guo S., Chen Y., Pang C., Wang X., Qi J., Mo L., et al. . (2017). Ginsenoside Rb1, a novel activator of the TMEM16A chloride channel, augments the contraction of guinea pig ileum. Pflugers Arch. 469, 681–692. 10.1007/s00424-017-1934-x PubMed DOI

Guo S., Chen Y., Pang C., Wang X., Shi S., Zhang H., et al. . (2018). Matrine is a novel inhibitor of the TMEM16A chloride channel with antilung adenocarcinoma effects. J. Cell Physiol. [Epub ahead of print]. 10.1002/jcp.27529 PubMed DOI

Hajj R., Lesimple P., Nawrocki-Raby B., Birembaut P., Puchelle E., Coraux C. (2007). Human airway surface epithelial regeneration is delayed and abnormal in cystic fibrosis. J. Pathol. 211, 340–350. 10.1002/path.2118 PubMed DOI

Heinze C., Seniuk A., Sokolov M. V., Huebner A. K., Klementowicz A. E., Szijarto I. A., et al. . (2014). Disruption of vascular Ca2+-activated chloride currents lowers blood pressure. J. Clin. Invest. 124, 675–686. 10.1172/JCI70025 PubMed DOI PMC

Hoegger M. J., Fischer A. J., Mcmenimen J. D., Ostedgaard L. S., Tucker A. J., Awadalla M. A., et al. . (2014). Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis. Science 345, 818–822. 10.1126/science.1255825 PubMed DOI PMC

Hogg R. C., Wang Q., Large W. A. (1994). Action of niflumic acid on evoked and spontaneous calcium-activated chloride and potassium currents in smooth muscle cells from rabbit portal vein. Br. J. Pharmacol. 112, 977–984. 10.1111/j.1476-5381.1994.tb13177.x PubMed DOI PMC

Huang F., Rock J. R., Harfe B. D., Cheng T., Huang X., Jan Y. N., et al. . (2009). Studies on expression and function of the TMEM16A calcium-activated chloride channel. Proc. Natl. Acad. Sci. U.S.A. 106, 21413–21418. 10.1073/pnas.0911935106 PubMed DOI PMC

Huang F., Zhang H., Wu M., Yang H., Kudo M., Peters C. J., et al. . (2012). Calcium-activated chloride channel TMEM16A modulates mucin secretion and airway smooth muscle contraction. Proc. Natl. Acad. Sci. U.S.A. 109, 16354–16359. 10.1073/pnas.1214596109 PubMed DOI PMC

Huang Y., Guo S., Ren S., Chen Y., Zhan Y., An H. (2018). The natural compound cinnamaldehyde is a novel activator of calcium-activated chloride channel. J. Membr. Biol. 251, 747–756. 10.1007/s00232-018-0052-9 PubMed DOI

Hutt D. M., Loguercio S., Roth D. M., Su A. I., Balch W. E. (2018). Correcting the F508del-CFTR variant by modulating eukaryotic translation initiation factor 3-mediated translation initiation. J. Biol. Chem. 293, 13477–13495. 10.1074/jbc.RA118.003192 PubMed DOI PMC

Itani O. A., Chen J. H., Karp P. H., Ernst S., Keshavjee S., Parekh K., et al. (2011). Human cystic fibrosis airway epithelia have reduced Cl− conductance but not increased Na+ conductance. Proc. Natl. Acad. Sci. U.S.A. 108, 10260–10265. 10.1073/pnas.1106695108 PubMed DOI PMC

Jiang Y., Yu B., Yang H., Ma T. (2016). Shikonin inhibits intestinal calcium-activated chloride channels and prevents rotaviral diarrhea. Front. Pharmacol. 7:270. 10.3389/fphar.2016.00270 PubMed DOI PMC

Keating D., Marigowda G., Burr L., Daines C., Mall M. A., Mckone E. F., et al. (2018). VX-445-Tezacaftor-Ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles. N. Engl. J. Med. 379, 1612–1620. 10.1056/NEJMoa1807120 PubMed DOI PMC

Khan T. Z., Wagener J. S., Bost T., Martinez J., Accurso F. J., Riches D. W. (1995). Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151, 1075–1082. PubMed

Klymiuk N., Mundhenk L., Kraehe K., Wuensch A., Plog S., Emrich D., et al. . (2012). Sequential targeting of CFTR by BAC vectors generates a novel pig model of cystic fibrosis. J. Mol. Med. 90, 597–608. 10.1007/s00109-011-0839-y PubMed DOI

Knight D. (2004). Talniflumate (Genaera). Curr. Opin. Investig. Drugs 5, 557–562. PubMed

Knowles M. R., Boucher R. C. (2002). Mucus clearance as a primary innate defense mechanism for mammalian airways. J. Clin. Invest. 109, 571–577. 10.1172/JCI0215217 PubMed DOI PMC

Kondo M., Nakata J., Arai N., Izumo T., Tagaya E., Takeyama K., et al. . (2012). Niflumic acid inhibits goblet cell degranulation in a guinea pig asthma model. Allergol. Int. 61, 133–142. 10.2332/allergolint.11-OA-0307 PubMed DOI

Kondo M., Tsuji M., Hara K., Arimura K., Yagi O., Tagaya E., et al. . (2017). Chloride ion transport and overexpression of TMEM16A in a guinea pig asthma model. Clin. Exp. Allergy 47, 795–804. 10.1111/cea.12887 PubMed DOI

Kubitz R., Warth R., Kunzelmann K., Grolik M., Greger R. (1992). Small conductance Cl− channels induced by cAMP, Ca2+, and hypotonicity in HT29 cells: ion selectivity, additivity and stilbene sensitivity. Pflügers Arch. 421, 447–454. 10.1007/BF00370255 PubMed DOI

Kunzelmann K., Cabrita I., Wanitchakool P., Ousingsawat J., Sirianant L., Benedetto R., et al. (2016). Modulating Ca2+signals: a common theme for TMEM16, Ist2, and TMC. Pflügers Arch. 468, 475–490. 10.1007/s00424-015-1767-4 PubMed DOI

Kunzelmann K., Gerlach L., Fröbe U., Greger R. (1991). Bicarbonate permeability of epithelial chloride channels. Pflügers Arch. 417, 616–621. 10.1007/BF00372960 PubMed DOI

Kunzelmann K., Kubitz R., Grolik M., Warth R., Greger R. (1992). Small conductance Cl− channels in HT29 cells: activation by Ca2+, hypotonic cell swelling and 8-Br-cGMP. Pflügers Arch. 421, 238–246. 10.1007/BF00374833 PubMed DOI

Kunzelmann K., Mall M., Briel M., Hipper A., Nitschke R., Ricken S., et al. (1997). The cystic fibrosis transmembrane conductance regulator attenuates the endogenous Ca2+ activated Cl− conductance in Xenopus ooyctes. Pflügers Arch. 434, 178–181. 10.1007/s004240050498 PubMed DOI

Kunzelmann K., Nilius B., Owsianik G., Schreiber R., Ousingsawat J., Sirianant L., et al. (2014). Molecular functions of anoctamin 6 (TMEM16F): a chloride channel, cation channel or phospholipid scramblase? Pflügers Arch. 466, 407–414. 10.1007/s00424-013-1305-1 PubMed DOI

Kunzelmann K., Schreiber R., Cook D. I. (2002). Mechanisms for inhibition of amiloride-sensitive Na+ absorption by extracellular nuceotides in mouse trachea. Pflügers Arch. 444, 220–226. 10.1007/s00424-002-0796-y PubMed DOI

Kunzelmann K., Schreiber R., Hadorn H. B. (2017). Bicarbonate in cystic fibrosis. J. Cyst. Fibros. 16, 653–662. 10.1016/j.jcf.2017.06.005 PubMed DOI

Kunzelmann K., Tian Y., Martins J. R., Faria D., Kongsuphol P., Ousingsawat J., et al. . (2011). Anoctamins. Pflugers Arch. 462, 195–208. 10.1007/s00424-011-0975-9 PubMed DOI

Kunzelmann K., Tian Y., Martins J. R., Faria D., Kongsuphol P., Ousingsawat J., et al. (2012). Cells in focus: airway epithelial cells-Functional links between CFTR and anoctamin dependent Cl(-) secretion. Int. J. Biochem. Cell Biol. 44, 1897–1900. 10.1016/j.biocel.2012.06.011 PubMed DOI

Lee B., Cho H., Jung J., Yang Y. D., Yang D. J., Oh U. (2014). Anoctamin 1 contributes to inflammatory and nerve-injury induced hypersensitivity. Mol. Pain 10:5. 10.1186/1744-8069-10-5 PubMed DOI PMC

Lerias J., Pinto M., Benedetto R., Schreiber R., Amaral M., Aureli M., et al. . (2018). Compartmentalized crosstalk of CFTR and TMEM16A (ANO1) through EPAC1 and ADCY1. Cell. Signal. 44, 10–19. 10.1016/j.cellsig.2018.01.008 PubMed DOI

Li H., Salomon J. J., Sheppard D. N., Mall M. A., Galietta L. J. (2017). Bypassing CFTR dysfunction in cystic fibrosis with alternative pathways for anion transport. Curr. Opin. Pharmacol. 34, 91–97. 10.1016/j.coph.2017.10.002 PubMed DOI

Lin J., Jiang Y., Li L., Liu Y., Tang H., Jiang D. (2015). TMEM16A mediates the hypersecretion of mucus induced by Interleukin-13. Exp. Cell Res. 334, 260–269. 10.1016/j.yexcr.2015.02.026 PubMed DOI

Mall M., Bleich M., Greger R., Schreiber R., Kunzelmann K. (1998a). The amiloride inhibitable Na+ conductance is reduced by CFTR in normal but not in CF airways. J. Clin. Invest. 102, 15–21. 10.1172/JCI2729 PubMed DOI PMC

Mall M., Bleich M., Greger R., Schürlein M., Kühr J., Seydewitz H. H., et al. (1998b). Cholinergic ion secretion in human colon requires co-activation by cAMP. Am. J. Physiol. 275, G1274–G1281. PubMed

Mall M., Gonska T., Thomas J., Schreiber R., Seydewitz H. H., Kuehr J., et al. . (2003). Modulation of Ca2+ activated Cl− secretion by basolateral K+ channels in human normal and cystic fibrosis airway epithelia. Pediatr. Res. 53, 608–618. 10.1203/01.PDR.0000057204.51420.DC PubMed DOI

Mall M., Grubb B. R., Harkema J. R., O'neal W. K., Boucher R. C. (2004). Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nat. Med. 10, 487–493. 10.1038/nm1028 PubMed DOI

Mall M., Wissner A., Kühr J., Gonska T., Brandis M., Kunzelmann K. (2000). Inhibition of amiloride sensitive epithelial Na+ absorption by extracellular nucleotides in human normal and CF airways. Am. J. Respir. Cell Mol. Biol. 23, 755–761. 10.1165/ajrcmb.23.6.4207 PubMed DOI

Martins J. R., Kongsuphol P., Sammels E., Daimène S., Aldehni F., Clarke L., et al. (2011). F508del-CFTR increases intracellular Ca2+ signaling that causes enhanced calcium-dependent Cl− conductance in cystic fibrosis. Biochim. Biophys. Acta 1812, 1385–1392. 10.1016/j.bbadis.2011.08.008 PubMed DOI

Matsui H., Grubb B. R., Tarran R., Randell S. H., Gatzy J. T., Davis C. W., et al. (1998). Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95, 1005–1015. 10.1016/S0092-8674(00)81724-9 PubMed DOI

Miller M. R., Soave D., Li W., Gong J., Pace R. G., Boelle P. Y., et al. . (2015). Variants in solute carrier SLC26A9 modify prenatal exocrine pancreatic damage in cystic fibrosis. J. Pediatr. 166, 1152–1157.e1156. 10.1016/j.jpeds.2015.01.044 PubMed DOI PMC

Miner K., Mohn D., Elliot R., Powers D., Chen J., Liu B., et al. (2019). The anthelminthic niclosamide and related compounds represent potent Tmem16a antagonists that fully relax mouse and human airway rings. Front. Pharmacol. (in press).

Montoro D. T., Haber A. L., Biton M., Vinarsky V., Lin B., Birket S. E., et al. . (2018). A revised airway epithelial hierarchy includes CFTR-expressing ionocytes. Nature 560, 319–324. 10.1038/s41586-018-0393-7 PubMed DOI PMC

Moody M., Pennington C., Schultz C., Caldwell R., Dinkel C., Rossi M. W., et al. . (2005). Inositol polyphosphate derivative inhibits Na+ transport and improves fluid dynamics in cystic fibrosis airway epithelia. Am. J. Physiol. Cell Physiol. 289, C512–C520. 10.1152/ajpcell.00591.2004 PubMed DOI PMC

Moss R. B. (2013). Pitfalls of drug development: lessons learned from trials of denufosol in cystic fibrosis. J. Pediatr. 162, 676–680. 10.1016/j.jpeds.2012.11.034 PubMed DOI

Mount D. B., Romero M. F. (2004). The SLC26 gene family of multifunctional anion exchangers. Pflugers Arch. 447, 710–721. 10.1007/s00424-003-1090-3 PubMed DOI

Namkung W., Finkbeiner W. E., Verkman A. S. (2010a). CFTR-Adenylyl cyclase I association is responsible for UTP activation of CFTR in well-differentiated primary human bronchial cell cultures. Mol. Biol. Cell 21, 2639–2648. 10.1091/mbc.e09-12-1004 PubMed DOI PMC

Namkung W., Phuan P. W., Verkman A. S. (2011a). TMEM16A inhibitors reveal TMEM16A as a minor component of CaCC conductance in airway and intestinal epithelial cells. J. Biol. Chem. 286, 2365–2374. 10.1074/jbc.M110.175109 PubMed DOI PMC

Namkung W., Thiagarajah J. R., Phuan P. W., Verkman A. S. (2010b). Inhibition of Ca2+-activated Cl− channels by gallotannins as a possible molecular basis for health benefits of red wine and green tea. FASEB J. 24, 4178–4186. 10.1096/fj.10-160648 PubMed DOI PMC

Namkung W., Yao Z., Finkbeiner W. E., Verkman A. S. (2011b). Small-molecule activators of TMEM16A, a calcium-activated chloride channel, stimulate epithelial chloride secretion and intestinal contraction. FASEB J. 25, 4048–4062. 10.1096/fj.11-191627 PubMed DOI PMC

Oh S. J., Hwang S. J., Jung J., Yu K., Kim J., Choi J. Y., et al. (2013). MONNA, a potent and selective blocker for TMEM16A/Anoctamin-1. Mol. Pharmacol. 84, 726–735. 10.1124/mol.113.087502 PubMed DOI PMC

Ousingsawat J., Kongsuphol P., Schreiber R., Kunzelmann K. (2011a). CFTR and TMEM16A are separate but functionally related Cl channels. Cell. Physiol. Biochem. 28, 715–724. 10.1159/000335765 PubMed DOI

Ousingsawat J., Martins J. R., Schreiber R., Rock J. R., Harfe B. D., Kunzelmann K. (2009). Loss of TMEM16A causes a defect in epithelial Ca2+ dependent chloride transport. J. Biol. Chem. 284, 28698–28703. 10.1074/jbc.M109.012120 PubMed DOI PMC

Ousingsawat J., Schreiber R., Kunzelmann K. (2011b). Differential contribution of SLC26A9 to Cl(-) conductance in polarized and non-polarized epithelial cells. J. Cell. Physiol. 227, 2323–2329. 10.1002/jcp.22967 PubMed DOI

Ousingsawat J., Wanitchakool P., Kmit A., Romao A. M., Jantarajit W., Schreiber S., et al. . (2015). Anoctamin 6 mediates effects essential for innate immunity downstream of P2X7-receptors in macrophages. Nat. Commun. 6:6245. 10.1038/ncomms7245 PubMed DOI

Paulino C., Kalienkova V., Lam A. K. M., Neldner Y., Dutzler R. (2017a). Activation mechanism of the calcium-activated chloride channel TMEM16A revealed by cryo-EM. Nature 552, 421–425. 10.1038/nature24652 PubMed DOI

Paulino C., Neldner Y., Lam A. K., Kalienkova V., Brunner J. D., Schenck S., et al. . (2017b). Structural basis for anion conduction in the calcium-activated chloride channel TMEM16A. Elife 6:e26232. 10.7554/eLife.26232 PubMed DOI PMC

Pedemonte N., Galietta L. J. (2014). Structure and function of TMEM16 proteins (anoctamins). Physiol. Rev. 94, 419–459. 10.1152/physrev.00039.2011 PubMed DOI

Pedersen K. A., Schroder R. L., Skaaning-Jensen B., Strobaek D., Olesen S. P., Christophersen P. (1999). Activation of the human intermediate-conductance Ca2+)-activated K+ channel by 1-ethyl-2-benzimidazolinone is strongly Ca2+-dependent. Biochim. Biophys. Acta 1420, 231–240. 10.1016/S0005-2736(99)00110-8 PubMed DOI

Pezzulo A. A., Tang X. X., Hoegger M. J., Alaiwa M. H., Ramachandran S., Moninger T. O., et al. . (2012). Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature 487, 109–113. 10.1038/nature11130 PubMed DOI PMC

Plasschaert L. W., Zilionis R., Choo-Wing R., Savova V., Knehr J., Roma G., et al. . (2018). A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte. Nature 560, 377–381. 10.1038/s41586-018-0394-6 PubMed DOI PMC

Poulsen J. H., Fischer H., Illek B., Machen T. E. (1994). Bicarbonate conductance and pH regulatory capability of cystic fibrosis transmembrane conductance regulator. Proc. Natl. Acad. Sci. U.S.A 91, 5340–5344. 10.1073/pnas.91.12.5340 PubMed DOI PMC

Pranke I. M., Hatton A., Simonin J., Jais J. P., Le Pimpec-Barthes F., Carsin A., et al. . (2017). Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators. Sci. Rep. 7:7375. 10.1038/s41598-017-07504-1 PubMed DOI PMC

Preston P., Wartosch L., Gunzel D., Fromm M., Kongsuphol P., Ousingsawat J., et al. . (2010). Disruption of the K+ channel beta-subunit KCNE3 reveals an important role in intestinal and tracheal Cl− transport. J. Biol. Chem. 285, 7165–7175. 10.1074/jbc.M109.047829 PubMed DOI PMC

Pusch M., Zifarelli G. (2014). Thermal sensitivity of CLC and TMEM16 chloride channels and transporters. Curr. Top. Membr. 74, 213–231. 10.1016/B978-0-12-800181-3.00008-7 PubMed DOI

Quinton P. M. (2001). The neglected ion: PubMed DOI

Ratjen F., Durham T., Navratil T., Schaberg A., Accurso F. J., Wainwright C., et al. . (2012). Long term effects of denufosol tetrasodium in patients with cystic fibrosis. J. Cyst. Fibros. 11, 539–549. 10.1016/j.jcf.2012.05.003 PubMed DOI

Ribeiro C. M., Paradiso A. M., Schwab U., Perez-Vilar J., Jones L., O'neal W., et al. . (2005). Chronic airway infection/Inflammation Induces a Ca2+i-dependent hyperinflammatory response in human cystic fibrosis airway epithelia. J. Biol. Chem. 280, 17798–17806. 10.1074/jbc.M410618200 PubMed DOI

Rottner M., Freyssinet J. M., Martinez M. C. (2009). Mechanisms of the noxious inflammatory cycle in cystic fibrosis. Respir. Res. 10:23. 10.1186/1465-9921-10-23 PubMed DOI PMC

Rottner M., Kunzelmann C., Mergey M., Freyssinet J. M., Martinez M. C. (2007). Exaggerated apoptosis and NF-kappaB activation in pancreatic and tracheal cystic fibrosis cells. FASEB J. 21, 2939–2948. 10.1096/fj.06-7614com PubMed DOI

Rottner M., Tual-Chalot S., Mostefai H. A., Andriantsitohaina R., Freyssinet J. M., Martinez M. C. (2011). Increased oxidative stress induces apoptosis in human cystic fibrosis cells. PLoS ONE 6:e24880. 10.1371/journal.pone.0024880 PubMed DOI PMC

Rowe S. M., Daines C., Ringshausen F. C., Kerem E., Wilson J., Tullis E., et al. . (2017). Tezacaftor-Ivacaftor in residual-function heterozygotes with cystic fibrosis. N. Engl. J. Med. 377, 2024–2035. 10.1056/NEJMoa1709847 PubMed DOI PMC

Ruffin M., Voland M., Marie S., Bonora M., Blanchard E., Blouquit-Laye S., et al. . (2013). Anoctamin 1 dysregulation alters bronchial epithelial repair in cystic fibrosis. Biochim. Biophys. Acta 1832, 2340–2351. 10.1016/j.bbadis.2013.09.012 PubMed DOI

Sanders K. M., Zhu M. H., Britton F., Koh S. D., Ward S. M. (2012). Anoctamins and gastrointestinal smooth muscle excitability. Exp. Physiol. 97, 200–206. 10.1113/expphysiol.2011.058248 PubMed DOI PMC

Schenk L. K., Buchholz B., Henke S. F., Michgehl U., Daniel C., Amann K., et al. . (2018). Nephron-specific knockout of TMEM16A leads to reduced number of glomeruli and albuminuria. Am. J. Physiol. Renal Physiol. [Epub ahead of print]. 10.1152/ajprenal.00638.2017 PubMed DOI

Schreiber R., Faria D., Skryabin B. V., Rock J. R., Kunzelmann K. (2014). Anoctamins support calcium-dependent chloride secretion by facilitating calcium signaling in adult mouse intestine. Pflügers Arch. 467, 1203–1213. 10.1007/s00424-014-1559-2 PubMed DOI

Schreiber R., Ousingsawat J., Wanitchakool P., Sirianant L., Benedetto R., Reiss K., et al. . (2018). Regulation of TMEM16A/ANO1 and TMEM16F/ANO6 ion currents and phospholipid scrambling by Ca2+ and plasma membrane lipid. J. Physiol. 596, 217–229. 10.1113/JP275175 PubMed DOI PMC

Schreiber R., Uliyakina I., Kongsuphol P., Warth R., Mirza M., Martins J. R., et al. . (2010). Expression and function of epithelial anoctamins. J. Biol. Chem. 285, 7838–7845. 10.1074/jbc.M109.065367 PubMed DOI PMC

Schultz A., Puvvadi R., Borisov S. M., Shaw N. C., Klimant I., Berry L. J., et al. (2017). Airway surface liquid pH is not acidic in children with cystic fibrosis. Nat. Commun. 8:1409 10.1038/s41467-017-00532-5 PubMed DOI PMC

Scudieri P., Caci E., Bruno S., Ferrera L., Schiavon M., Sondo E., et al. . (2012). Association of TMEM16A chloride channel overexpression with airway goblet cells metaplasia. J. Physiol. 590, 6141–6155. 10.1113/jphysiol.2012.240838 PubMed DOI PMC

Scudieri P., Caci E., Venturini A., Sondo E., Pianigiani G., Marchetti C., et al. . (2015). Ion channel and lipid scramblase activity associated with expression of tmem16F/ANO6 isoforms. J. Physiol. 593, 3829–3848. 10.1113/JP270691 PubMed DOI PMC

Seo Y., Kim J., Chang J., Kim S. S., Namkung W., Kim I. (2018). Synthesis and biological evaluation of novel Ani9 derivatives as potent and selective ANO1 inhibitors. Eur. J. Med. Chem. 160, 245–255. 10.1016/j.ejmech.2018.10.002 PubMed DOI

Seo Y., Lee H. K., Park J., Jeon D. K., Jo S., Jo M., et al. . (2016). Ani9, a novel potent small-molecule ANO1 inhibitor with negligible effect on ANO2. PLoS ONE 11:e0155771. 10.1371/journal.pone.0155771 PubMed DOI PMC

Seo Y., Park J., Kim M., Lee H. K., Kim J. H., Jeong J. H., et al. . (2015). Inhibition of ANO1/TMEM16A chloride channel by idebenone and its cytotoxicity to cancer cell lines. PLoS ONE 10:e0133656. 10.1371/journal.pone.0133656 PubMed DOI PMC

Sharm K., Sung J., Kim H. J., Oak M. H., Yi E. (2017). Rice bran extract inhibits TMEM16A-Involved activity in the neonatal rat cochlea. J. Nanosci. Nanotechnol. 17, 2390–2393. 10.1166/jnn.2017.13333 PubMed DOI

Shimizu T., Iehara T., Sato K., Fujii T., Sakai H., Okada Y. (2013). TMEM16F is a component of a Ca2+-activated Cl− channel but not a volume-sensitive outwardly rectifying Cl− channel. Am. J. Physiol. Cell Physiol. 304, C748–C759. 10.1152/ajpcell.00228.2012 PubMed DOI

Singh R. D., Gibbons S. J., Saravanaperumal S. A., Du P., Hennig G. W., Eisenman S. T., et al. . (2014). Ano1, a Ca2+-activated Cl− channel coordinates contractility in mouse intestine by ca2+ transient coordination between interstitial cells of cajal. J. Physiol. 592, 4051–4068. 10.1113/jphysiol.2014.277152 PubMed DOI PMC

Sirianant L., Ousingsawat J., Wanitchakool P., Schreiber R., Kunzelmann K. (2015). Cellular volume regulation by anoctamin 6:Ca2+, phospholipase A2, osmosensing. Pflügers Arch. 468, 335–349. 10.1007/s00424-015-1739-8 PubMed DOI

Smith J. J., Welsh M. J. (1992). cAMP stimulates bicarbonate secretion across normal, but not cystic fibrosis airway epithelia. J. Clin. Invest. 89, 1148–1153. 10.1172/JCI115696 PubMed DOI PMC

Stick S. M., Schultz A. (2018). CrossTalk opposing view: mucosal acidification does not drive early progressive lung disease in cystic fibrosis. J. Physiol. 596, 3439–3441. 10.1113/JP275426 PubMed DOI PMC

Stoltz D. A., Meyerholz D. K., Pezzulo A. A., Ramachandran S., Rogan M. P., Davis G. J., et al. . (2010). Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci. Transl. Med. 2:29ra31. 10.1126/scitranslmed.3000928 PubMed DOI PMC

Stoltz D. A., Meyerholz D. K., Welsh M. J. (2015). Origins of cystic fibrosis lung disease. N. Engl. J. Med. 372, 351–362. 10.1056/NEJMra1300109 PubMed DOI PMC

Strug L. J., Gonska T., He G., Keenan K., Ip W., Boelle P. Y., et al. . (2016). Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics. Hum. Mol. Genet. 25, 4590–4600. 10.1093/hmg/ddw290 PubMed DOI PMC

Sui Y., Wu F., Lv J., Li H., Li X., Du Z., et al. . (2015). Identification of the novel TMEM16A Inhibitor dehydroandrographolide and its anticancer activity on SW620 cells. PLoS ONE 10:e0144715. 10.1371/journal.pone.0144715 PubMed DOI PMC

Sun L., Rommens J. M., Corvol H., Li W., Li X., Chiang T. A., et al. . (2012). Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis. Nat. Genet. 44, 562–569. 10.1038/ng.2221 PubMed DOI PMC

Suzuki J., Umeda M., Sims P. J., Nagata S. (2010). Calcium-dependent phospholipid scrambling by TMEM16F. Nature 468, 834–838. 10.1038/nature09583 PubMed DOI

Ta C. M., Adomaviciene A., Rorsman N. J., Garnett H., Tammaro P. (2016). Mechanism of allosteric activation of TMEM16A/ANO1 channels by a commonly used chloride channel blocker. Br. J. Pharmacol. 173, 511–528. 10.1111/bph.13381 PubMed DOI PMC

Tang L., Fatehi M., Linsdell P. (2009). Mechanism of direct bicarbonate transport by the CFTR anion channel. J. Cyst. Fibros. 8, 115–121. 10.1016/j.jcf.2008.10.004 PubMed DOI

Taylor-Cousar J. L., Munck A., Mckone E. F., Van Der Ent C. K., Moeller A., Simard C., et al. . (2017). Tezacaftor-Ivacaftor in patients with cystic fibrosis homozygous for Phe508del. N. Engl. J. Med. 377, 2013–2023. 10.1056/NEJMoa1709846 PubMed DOI

Tian Y., Schreiber R., Kunzelmann K. (2012a). Anoctamins are a family of Ca2+ activated Cl− channels. J. Cell Sci. 125, 4991–4998. 10.1242/jcs.109553 PubMed DOI

Tian Y., Schreiber R., Wanitchakool P., Kongsuphol P., Sousa M., Uliyakina I., et al. . (2012b). Control of TMEM16A by INO-4995 and other inositolphosphates. Br. J. Pharmacol. 168, 253–265. 10.1111/j.1476-5381.2012.02193.x PubMed DOI PMC

Tirkos S., Newbigging S., Nguyen V., Keet M., Ackerley C., Kent G., et al. . (2006). Expression of S100A8 correlates with inflammatory lung disease in congenic mice deficient of the cystic fibrosis transmembrane conductance regulator. Respir. Res. 7:51. 10.1186/1465-9921-7-51 PubMed DOI PMC

Tradtrantip L., Namkung W., Verkman A. S. (2010). Crofelemer, an antisecretory antidiarrheal proanthocyanidin oligomer extracted from Croton lechleri, targets two distinct intestinal chloride channels. Mol. Pharmacol. 77, 69–78. 10.1124/mol.109.061051 PubMed DOI PMC

Trout L., King M., Feng W., Inglis S. K., Ballard S. T. (1998). Inhibition of airway liquid secretion and its effect on the physical properties of airway mucus. Am. J. Physiol. 274, L258–L263. 10.1152/ajplung.1998.274.2.L258 PubMed DOI

Truong E. C., Phuan P. W., Reggi A. L., Ferrera L., Galietta L. J. V., Levy S. E., et al. . (2017). Substituted 2-acylaminocycloalkylthiophene-3-carboxylic acid arylamides as inhibitors of the calcium-activated chloride channel transmembrane protein 16A (TMEM16A). J. Med. Chem. 60, 4626–4635. 10.1021/acs.jmedchem.7b00020 PubMed DOI PMC

Vajanaphanich M., Schultz C., Rudolf M. T., Wasserman M., Enyedi P., Craxton A., et al. . (1994). Long-term uncoupling of chloride secretion from intracellular calcium levels by Ins(3,4,5,6)P4. Nature 371, 711–714. 10.1038/371711a0 PubMed DOI

Van Goor F., Hadida S., Grootenhuis P. D., Burton B., Cao D., Neuberger T., et al. . (2009). Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc. Natl. Acad. Sci. U.S.A. 106, 18825–18830. 10.1073/pnas.0904709106 PubMed DOI PMC

Van Goor F., Hadida S., Grootenhuis P. D., Burton B., Stack J. H., Straley K. S., et al. . (2011). Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc. Natl. Acad. Sci. U.S.A. 108, 18843–18848. 10.1073/pnas.1105787108 PubMed DOI PMC

Veit G., Avramescu R. G., Perdomo D., Phuan P. W., Bagdany M., Apaja P. M., et al. . (2014). Some gating potentiators, including VX-770, diminish DeltaF508-CFTR functional expression. Sci. Transl. Med. 6:246ra297. 10.1126/scitranslmed.3008889 PubMed DOI PMC

Verkman A. S., Galietta L. J. (2009). Chloride channels as drug targets. Nat. Rev. Drug Discov. 8, 153–171. 10.1038/nrd2780 PubMed DOI PMC

Villalba J. M., Parrado C., Santos-Gonzalez M., Alcain F. J. (2010). Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations. Expert Opin. Investig. Drugs 19, 535–554. 10.1517/13543781003727495 PubMed DOI

Wainwright C. E., Elborn J. S., Ramsey B. W., Marigowda G., Huang X., Cipolli M., et al. (2015). Lumacaftor-Ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR. N. Engl. J. Med. 373, 220–231. 10.1056/NEJMoa1409547 PubMed DOI PMC

Walker N. M., Simpson J. E., Levitt R. C., Boyle K. T., Clarke L. L. (2006). Talniflumate increases survival in a cystic fibrosis mouse model of distal intestinal obstructive syndrome. J. Pharmacol. Exp. Ther. 317, 275–283. 10.1124/jpet.105.094847 PubMed DOI

Wang H., Zou L., Ma K., Yu J., Wu H., Wei M., et al. . (2017). Cell-specific mechanisms of TMEM16A Ca2+-activated chloride channel in cancer. Mol. Cancer 16:152. 10.1186/s12943-017-0720-x PubMed DOI PMC

Wang P., Zhao W., Sun J., Tao T., Chen X., Zheng Y. Y., et al. (2018). Inflammatory mediators mediate airway smooth muscle contraction through a GPCR-TMEM16A-VDCC axis and contribute to bronchial hyperresponsiveness in asthma. J. Allergy Clin. Immunol. 141, 1259–1268. 10.1016/j.jaci.2017.05.053 PubMed DOI

Wanitchakool P., Ousingsawat J., Sirianant L., Macaulay N., Schreiber R., Kunzelmann K. (2016). Cl− channels in apoptosis. Eur. Biophys. J. 45, 599–610. 10.1007/s00249-016-1140-3 PubMed DOI

Wanitchakool P., Wolf L., Koehl G., Sirianant L., Gaumann A., Schreiber R., et al. . (2014). Role of anoctamins in cancer and apoptosis. Philos. Trans. R. Soc. Lond. B Biol. Sci. 369:20130096. 10.1098/rstb.2013.0096 PubMed DOI PMC

Wei L., Vankeerberghen A., Cuppens H., Eggermont J., Cassiman J. J., Droogmans G., et al. . (1999). Interaction between calcium-activated chloride channels and the cystic fibrosis transmembrane conductance regulator. Pflugers Arch. 438, 635–641. 10.1007/s004249900108 PubMed DOI

White M. M., Aylwin M. (1990). Niflumic and flufenamic acids are potent reversible blockers of Ca2+-activated Cl− channels in Xenopus oocytes. Mol. Pharmacol. 37, 720–724. PubMed

Wilke M., Buijs-Offerman R. M., Aarbiou J., Colledge W. H., Sheppard D. N., Touqui L., et al. . (2011). Mouse models of cystic fibrosis: phenotypic analysis and research applications. J. Cyst. Fibros. 10 (Suppl. 2), S152–171. 10.1016/S1569-1993(11)60020-9 PubMed DOI

Yang H., Kim A., David T., Palmer D., Jin T., Tien J., et al. . (2012). TMEM16F forms a Ca2+-activated cation channel required for lipid scrambling in platelets during blood coagulation. Cell 151, 111–122. 10.1016/j.cell.2012.07.036 PubMed DOI PMC

Yang Y. D., Cho H., Koo J. Y., Tak M. H., Cho Y., Shim W. S., et al. . (2008). TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature 455, 1210–1215. 10.1038/nature07313 PubMed DOI

Yerxa B. R., Sabater J. R., Davis C. W., Stutts M. J., Lang-Furr M., Picher M., et al. . (2002). Pharmacology of INS37217 [P(1)-(uridine 5')-P(4)- (2'-deoxycytidine 5')tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis. J Pharmacol. Exp. Ther. 302, 871–880. 10.1124/jpet.102.035485 PubMed DOI

Yim P. D., Gallos G., Perez-Zoghbi J. F., Trice J., Zhang Y., Siviski M., et al. . (2013). Chloride channel blockers promote relaxation of TEA-induced contraction in airway smooth muscle. J. Smooth Muscle Res. 49, 112–124. 10.1540/jsmr.49.112 PubMed DOI PMC

Zabner J., Smith J. J., Karp P. H., Widdicombe J. H., Welsh M. J. (1998). Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro. Mol. Cell 2, 397–403. 10.1016/S1097-2765(00)80284-1 PubMed DOI

Zhang C. H., Li Y., Zhao W., Lifshitz L. M., Li H., Harfe B. D., et al. (2013). The transmembrane protein 16A Ca2+-activated Cl− channel in airway smooth muscle contributes to airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 187, 374–381. 10.1164/rccm.201207-1303OC PubMed DOI PMC

Mucus Release and Airway Constriction by TMEM16A May Worsen Pathology in Inflammatory Lung Disease